Özyurt, N. Et Al. 2024. The prognostic impact of Her2 status in early triple negative breast cancer: a Turkish Oncology Group (TOG) study. Scientific reports , vol.14, no.1 , 23556.

Özyurt, N., Alkan, A., Gülbağcı, B., Seyyar, M., Aydın, E., Şahbazlar, M., ... Türker, M.(2024). The prognostic impact of Her2 status in early triple negative breast cancer: a Turkish Oncology Group (TOG) study. Scientific reports , vol.14, no.1, 23556.

Özyurt, Neslihan Et Al. "The prognostic impact of Her2 status in early triple negative breast cancer: a Turkish Oncology Group (TOG) study," Scientific reports , vol.14, no.1, 23556, 2024

Özyurt, Neslihan Et Al. "The prognostic impact of Her2 status in early triple negative breast cancer: a Turkish Oncology Group (TOG) study." Scientific reports , vol.14, no.1, pp.23556, 2024

Özyurt, N. Et Al. (2024) . "The prognostic impact of Her2 status in early triple negative breast cancer: a Turkish Oncology Group (TOG) study." Scientific reports , vol.14, no.1, p.23556.

@article{article, author={Neslihan Özyurt Et Al. }, title={The prognostic impact of Her2 status in early triple negative breast cancer: a Turkish Oncology Group (TOG) study}, journal={Scientific reports}, year=2024, pages={23556} }